In *Am J Trop Med Hyg 89:* 570--577 by Fernandes Cota and others, there is an error in the tables. The authors found a mistake categorization of gender in the study database, which resulted in presentation of an inverted proportion between male and female patients, thereby generating an error in Tables 1 and 2 of the published study. The correct Tables appear here. The authors and the journal regret this error.

###### 

Demographic and clinical characteristics of 113 HIV-infected patients who underwent diagnostic testing for VL

  Variable                                                                              Patients
  ------------------------------------------------------------------------------------- -----------------------------------
  Sex (male:female)                                                                     76:37
  Age, mean years + SD                                                                  40,42 ± 10.22
  Previous VL (%)                                                                       24/113 (21.2%)
  CD4 count, median (25--75% interquartile range)[\*](#TFN2){ref-type="table-fn"}       67 (37--164) cell/mm^3^
  PCR-HIV-1 load, median (25--75% interquartile range)[†](#TFN3){ref-type="table-fn"}   34.176 (79--184.370) copies/mm^3^
  ARV therapy use (%)                                                                   70/113 (61.9%)
  Fever more than 14 days (%)                                                           81/113 (71.7%)
  Cytopenia (%)                                                                         111/113 (98.2%)
  Splenomegaly (%)                                                                      50/113 (44.2%)
  Opportunist infection previously (%)                                                  67/113 (59.3%)

SD = standard deviation; VL = visceral leishmaniasis; PCR-HIV-1 = HIV load by real time polymerase chain reaction; ARV = anti-retroviral.

Available in 95 patients.

Available in 69 patients.

###### 

Clinical and laboratorial characteristics of patients with target condition (visceral leishmaniasis) present or absent according to adjudication committee definition

                                                          Target condition present, n = 46                      Target condition absent, n = 67                             *P* value
  ------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------------- -----------
  Age (mean ± SD)                                         41.02 ± 10.8                                          40.0 ± 9.8                                                  0.60
  Sex (male:female)                                       37:9                                                  39:28                                                       0.01
  Anti-HVC presence                                       2 (4.3%)                                              6 (9.5%)                                                    0.44
  HbsAg presence                                          0                                                     2 (3.2%)                                                    0.31
  Illicit drug use                                        16 (34.8%)                                            27 (40.3%)                                                  0.58
  Alcohol abuse                                           31 (67.4%)                                            40 (59.7%)                                                  0.39
  Previous VL diagnosis                                   20 (43.4%)                                            4 (5.9%)                                                    0.00
  Previous opportunist infection                          31 (67.4%)                                            36 (53.7%)                                                  0.17
  Previous schistosomiasis diagnosis                      3 (6.5%)                                              7 (10.4%)                                                   0.05
  Comorbidities                                           13 (28.3%)                                            16 (23.8%)                                                  0.64
  CD4+ T cell count (25--75% IR)                          67 (6--864)[\*](#TFN5){ref-type="table-fn"}           92 (5--483)[†](#TFN6){ref-type="table-fn"}                  0.18
  HIV-PCR load copies/mm^3^ (25--75% IR)                  5.000 (0--65.712)[‡](#TFN7){ref-type="table-fn"}      78.132 (7.412--316.650)[§](#TFN8){ref-type="table-fn"}      0.01
  Fever                                                   28 (60.8%)                                            53 (79.1%)                                                  0.06
  Cytopenia                                               46 (100%)                                             65 (97.0%)                                                  0.51
  Splenomegaly on physical exam                           35 (76%)                                              15 (22.4%)                                                  0.00
  Death in 30 days                                        4 (8.7%)                                              8 (11.9%)                                                   0.02
  ARV therapy use                                         32 (69.6%)                                            34 (50.7)                                                   0.15
  ARV therapy regular use                                 15/32 (46.8%)                                         7/34 (20.6)                                                 0.01
  Hemoglobin g/dl                                         8.2 ± 1.6                                             9.1 ± 2.4                                                   0.04
  Leucocytes count cell/L (25--75% IR)                    2.0 (1.75--2.80) × 10^9^                              3.3 (1.75--4.20) × 10^9^                                    0.005
  Platelets count cell/L (25--75% IR)                     114 (82.75--173.75) ×10^9^                            139 (90.50--244.50) ×10^9^                                  0.233
  rK39 dipstick test positivity                           21/46 (45.6%)                                         2/67 (3.0%)                                                 0.00
  IFAT positivity                                         28/46 (60.9%)                                         7/67 (10.4%)                                                0.00
  DAT-LPC positivity                                      41/46 (89%)                                           8/59 (13.6%)                                                0.00
  *Leishmania* qPCR in peripheral blood positivity        36/42 (85.7%)                                         4/60 (6.7%)                                                 0.00
  Median copies *Leishmania* qPCR in blood (25--75% IR)   16.543 (108--70.209)[∥](#TFN9){ref-type="table-fn"}   66.436 (5066--36.479.000)[¶](#TFN10){ref-type="table-fn"}   0.56

SD = standard deviation; Anti-HVC = antibody to the hepatitis C virus; HbsAg = hepatitis B surface antigen; ARV = anti-retroviral; PCR-HIV = real time polymerase chain reaction for HIV-1; qPCR = real time polymerase chain reaction for *Leishmania infantum.*

Performed in 43 patients.

Performed in 52 patients.

Performed in 29 patients.

Performed in 40 patients.

Available in 35 patients.

Available in 4 patients.
